Chemical formula: C₂₁H₂₇NO₄ Molecular mass: 357.443 g/mol PubChem compound: 5311304
Nalbuphine is an opioid with kappa-agonistic and mu-antagonistic properties. Beside the essential agonistic (analgesic) effect nalbuphine has antagonistic effects of about a fourth of nalorfine and ten times of pentazocine.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02AF02 | Nalbuphine | N Nervous system → N02 Analgesics → N02A Opioids → N02AF Morphinan derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| NUBAIN Solution for injection | Health Products and Food Branch (CA) | MPI, CA: SPM | |
| NALPAIN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Nalbuphine is an active ingredient of these brands:
Austria (AT)
Brazil (BR)
Canada (CA)
Estonia (EE)
France (FR)
Hong Kong (HK)
Ireland (IE)
Poland (PL)
South Africa (ZA)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
